Long before psilocybin entered clinical trials and ketamine appeared in mental health clinics, sacred plants and mind-altering substances were being used for healing, connection, and transformation. In Psychedelics A to Z: An Illustrated Journey Through the Captivating World of Psychedelics, Dr. Olga Chernoloz guides readers through the history, science, and cultural roots of psychedelic medicine. One of the clearest themes in her work is that today’s breakthroughs are not new—they’re remembered.
Across continents and millennia, indigenous cultures have used psychedelic plants to access altered states of consciousness. In “A is for Ayahuasca,” we learn that Amazonian tribes have long brewed this complex concoction for spiritual insight and healing. In Africa, iboga is central to the Bwiti tradition, used in rituals that mark life transitions. In Mexico, psilocybin mushrooms—known as “flesh of the gods”—have been consumed for divination, healing, and communion with the divine.
These traditions saw plants not as tools, but as teachers. They were used with intention, within ritual, and often with the guidance of elders. Psychedelics weren’t escapes from reality. They were bridges to it. Dr. Chernoloz points out that many of these ancient practices emphasized balance between body and spirit, human and nature, knowledge and humility.
Contrast that with the mid-20th-century Western approach, which began to isolate the active compounds in sacred plants. Scientists discovered LSD, synthesized psilocybin, and explored the unique properties of ketamine. These substances, once embedded in communal rituals, entered clinical and research spaces. And while this scientific interest produced important insights, it also brought unintended consequences.
By the 1970s, psychedelics became symbols of cultural rebellion, and the backlash was swift. As Dr. Chernoloz outlines in the “W is for War on Drugs” chapter, substances like LSD and MDMA were banned, despite promising therapeutic potential. The criminalization of psychedelics stalled research, erased indigenous knowledge from public discourse, and pushed healing underground.
It would take decades for science to catch up to what ancient traditions had always known: that these substances, when used with care and context, could help people heal.
Now, we are living in what many call the psychedelic renaissance. Psilocybin has shown potential in treating depression, end-of-life anxiety, and addiction. MDMA-assisted therapy is in late-stage trials for PTSD, showing results that few conventional treatments can match. Ketamine, once an anesthetic and club drug, is being administered in clinics across the world for treatment-resistant depression.
But the return of psychedelics isn’t just about new medications. It’s about reclaiming a deeper understanding of consciousness and healing. Dr. Chernoloz’s book makes it clear: clinical success depends not just on molecules, but on mindset, setting, and the meaning we give to the experience.
Many researchers and practitioners are now working to bring ancestral wisdom into modern therapy. They ask: How do we honor the cultural roots of these medicines? How do we use them not just for symptom relief, but for transformation? And how do we prevent the mistakes of the past—exploitation, commercialization, and overhype—from happening again?
Psychedelics A to Z bridges these worlds. It respects the old while embracing the new. It reminds us that the long journey of psychedelic healing didn’t begin in labs, and it shouldn’t end in them either.
